AUG 22, 2016 7:36 PM PDT

Flesh-Eating Bacteria in Patients with Rheumatoid Arthritis

WRITTEN BY: Kara Marker
A compound produced by the immune system triggers the recruitment of immune cells during an infection, but only with the proper signaling from other immune cells. However, recent research findings show that certain bacterial species can also activate the same compound. 
Credit: UC San Diego Health
Interleukin-1beta (IL-1beta) is first produced by the immune system as a long and inactive compound that requires cleavage for activation. While the body uses the inflammasome to cleave and activate IL-1beta, Group A Streptococcal bacteria produces its own enzyme called SpeB to do the same, which scientists from the University of California San Diego found in their recent study, published in the journal Science Immunology.

While it might seem counterintuitive that natural selection would favor a bacterial species that practically warned the host’s immune system of its presence, researchers from the study believe that the technique is to “wipe out competing bacteria” so Streptococcus can enter and dominate. 

First author Christopher LaRock, PhD said it also makes sense to for bacteria to inhibit SpeB production: “This finding may explain why some of the more invasive, flesh-eating strep strains have a genetic mutation that blocks SpeB production; it helps them avoid tripping the alarm and setting off an immune response.”

LaRock and the team analyzed data from a U.S. Food and Drug Administration database, looking for rheumatoid arthritis patients with extreme infections who also were known to be taking anakinra, an immunosuppressant drug that works by inhibiting IL-1beta activity. According to their findings, rheumatoid arthritis patients taking the drug were 300 times more likely than patients not taking the drug to experience “invasive, flesh-eating strep infections” from Group A Streptococcus species.

“With IL-1beta out of the picture, as is the case with patients taking anakinra, strep strains can progress to invasive infection while producing SpeB, which goes unnoticed by the immune system," LaRock said.

This study simultaneously revealed how vital IL-1beta is to effective immune protection and how important it is for doctors to consider doses and types of immunosuppressive drugs they give to patients. Rheumatoid arthritis is one of many autoimmune disorders that occur because of an overreaction of the immune system. While drugs that inhibit IL-1beta might help with flares of rheumatoid arthritis, infections with intense flesh-eating bacteria aren’t the right solution either. Doctors have to find a balance, including “close-monitoring and prophylactic antibiotics.”
 


Source: University of California San Diego
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
JUN 30, 2019
Cardiology
JUN 30, 2019
Opioid Addiction Comes With Increased Risk Of Infection
Public health officials have put decades of work into the battle against infectious diseases. Now, this progress is at risk of being dismantled. A recent s...
SEP 07, 2019
Immunology
SEP 07, 2019
A New Way To Fight Severe Peanut Allergies
Dr. Sandra Lin explains how SLIT is currently being used to treat allergies other than peanuts.    Over 1 million U.S. children have an allergy t...
OCT 02, 2019
Infographics
OCT 02, 2019
Surface Plasmon Resonance (SPR) Technology
Surface plasmon resonance (SPR) allows researchers to investigate different types of biomolecular interactions and mechanisms in real-time and label-free....
DEC 11, 2019
Drug Discovery & Development
DEC 11, 2019
Drug To Treat Ulcerative Colitis
Biomedical researchers at the University of California—Riverside, found that the therapeutic drug ‘tofacitinib’ used in treating autoimmu...
FEB 07, 2020
Neuroscience
FEB 07, 2020
Eating Fruits and Vegetables May Lower Alzheimer's Risk
New research has found that flavonols, a large class of compounds present in many fruits and vegetables, may be linked to a lower risk of developing Alzhei...
FEB 14, 2020
Immunology
FEB 14, 2020
Rewired natural killer cells show promising results in leukemia patients
Natural killer (NK) cells are a subset of white blood cells that are key players in the innate immune system, orchestrating host-rejection responses agains...
Loading Comments...